Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS’ Barry Straube Chats About Coverage-With-Evidence Development

This article was originally published in The Gray Sheet

Executive Summary

CMS plans to release its second coverage-with-evidence development (CED) guidance within the next couple of months, according to Acting Chief Medical Officer Barry Straube, MD
Advertisement

Related Content

Coverage With Evidence Development: Planning For Reimbursement On CMS’ Shifting Playing Field
Coverage With Evidence Development: Planning For Reimbursement On CMS’ Shifting Playing Field
FDA’s Gottlieb: Any FDA/CMS Collaboration Efforts Should Occur Postmarket
CMS Will Push For More Postmarket Data Transparency – Phurrough
CMS Issues “Coverage With Evidence Development” Draft Guidance
CMS Issues “Coverage With Evidence Development” Draft Guidance
Advertisement
UsernamePublicRestriction

Register

MT023077

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel